Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gut bacteria may soothe menopause symptoms — a trial puts it to the test

NCT ID NCT07759908

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether a daily synbiotic supplement, combining probiotics and a prebiotic fiber, can ease common perimenopause and menopause symptoms like poor sleep, anxiety, and brain fog. Women aged 44–55 experiencing these symptoms will take either the active supplement or a placebo for 8 weeks. The study also looks at effects on gut and vaginal health, offering a potential natural, non-hormonal approach to support women during this transition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
FemmeBiome Meno, a synbiotic supplement containing probiotics and prebiotics
What this could lead to
If it works, this could offer a natural, non-hormonal option to ease common menopause symptoms like sleep problems, anxiety, and brain fog.
What could go wrong
This is a small, early trial, and the specific blend hasn't been studied before. Results may not generalize, and benefits could be modest or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

49 people

The number who actually took part.

Started

Jun 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

44 to 55 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * To be eligible for inclusion, the Participant must fulfil all the following criteria: 1. Be able to give informed consent. 2. Be between 44 -55 years, inclusive. 3. Experiencing a score of \>4 on all of the symptoms below, within the past 12-months, measured by the MenQoL. 1. sleep disturbances 2. mood changes 3. changes in sexual function 4. Willing to consume the Study Product daily for the duration of the study. 5. Is in general good health, as determined by the investigator. Exclusion Criteria: Participants will be excluded from the study if they meet any of the following criteria: <!-- --> 1. Participants who are pregnant or wish to become pregnant during the study or who are lactating and/or currently breastfeeding. 2. Has food allergies or other issues with foods that would preclude intake of the Study Products or any known severe allergies. 3. Is experiencing surgical menopause (bilateral oophorectomy before natural menopause occurs). 4. Has any significant acute or chronic coexisting health conditions that would prevent them from fulfilling the study requirements, put the Participant at risk or would confound the interpretation of the study results as judged by the investigator on the basis of medical history. Excluded health conditions include: 1. Uterine fibroids (current or previous 12 months) 2. Endometriosis (current or past history) 3. Polycystic ovarian syndrome (current or past history) 4. History of abnormal pap smear (current or previous 12 months) 5. Enema (in the past 12-weeks) 5. Planned invasive medical procedures 3-weeks prior to and for the duration of the study. 6. Current or recent (in the past 4-weeks) use of a medication that the investigator believes would interfere with the objectives of the study or pose a safety risk or confound the interpretation of the study results. Prohibited medications include: 1. Antibiotics 2. Hormone replacement therapies (current or planned use) 3. Hormonal birth control (current or planned use) 4. Laxatives 7. Recent (in the past 12-weeks) initiation of supplements or herbal remedies commonly used to support perimenopause/menopause symptoms. 8. Current or recent (in the past 4-weeks) use of prohibited nutritional or non-nutritional supplements, including: 1. Probiotics 2. Prebiotics 3. Postbiotics 4. Fibre supplements 9. Planned major changes in lifestyle (i.e., diet, dieting, exercise level, travelling) during the duration of the study. 10. Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the study. 11. Participants may not be participating in other clinical studies. If the participant has previously taken part in an experimental study, the Investigator must ensure sufficient time has elapsed before entry to this study to ensure the integrity of the results.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Menopause are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Atlantia Clinical Trials

    Cork, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.